The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Use of Vancomycin or First-Generation Cephalosporins for the Treatment of Hemodialysis-Dependent Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia
Abstract
BACKGROUND: Because of its ease of dosing, vancomycin is commonly used to treat methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia in patients undergoing long-term hemodialysis. Clinical outcomes resulting from such a therapeutic strategy have not been well defined. METHODS: We prospectively identified patients undergoing long-term hemodialysis who received a diagnosis of MSSA bacteremia. Clinical outcomes were grouped according to the predominant antibiotic received during their therapy (vancomycin or a first-generation cephalosporin [cefazolin]). Treatment failure (defined as death or recurrent infection) was determined at 12 weeks after the initial positive blood culture results. A multivariable analysis was used to adjust for confounders. RESULTS: During an 84-month period, 123 hemodialysis-dependent patients with MSSA bacteremia were identified. Patients receiving vancomycin (n=77) tended to be younger (51 vs. 57 years; P=.06) and had a lower rates of metastatic complications at presentation (11.7% vs. 36.7%; P=.001) than did those receiving cefazolin (n=46). The 2 groups were similar with regard to Acute Physiology and Chronic Health Evaluation II scores, comorbidities, source of infection, type of hemodialysis access, and access removal rates. Treatment failure was more common among patients receiving vancomycin (31.2% vs. 13%; P=.02). In the multivariable analysis, factors independently associated with treatment failure included vancomycin use (odds ratio, 3.53; 95% confidence interval, 1.15-13.45) and retention of the hemodialysis access (odds ratio, 4.99; 95% confidence interval, 1.89-13.76). CONCLUSIONS: Hemodialysis-dependent patients with MSSA bacteremia treated with vancomycin are at a higher risk of experiencing treatment failure than are those receiving cefazolin. In the absence of patient specific circumstances (e.g., allergy to beta-lactams), vancomycin should not be continued beyond empirical therapy for hemodialysis-dependent patients with MSSA bacteremia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia
Fowler, V. G., Olsen, M. K., Corey, G. R., Woods, C. W., Cabell, C. H., Reller, L. B., Cheng, A. C., Dudley, T., & Oddone, E. Z. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.17.2066 · Cited by 652
Self-citationChang, F.-Y., Peacock, J. E., Musher, D. M., Triplett, P., MacDonald, B. B., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L. (2003) · Medicine · doi:10.1097/01.md.0000091184.93122.09 · Cited by 530
Marr, K. A., Sexton, D. J., Conlon, P. J., Corey, G. R., Schwab, S. J., & Kirkland, K. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-4-199708150-00003 · Cited by 513
Self-citationGonzalez, C., Rubio, M., Romero-Vivas, J., Gonzalez, M., & Picazo, J. J. (1999) · Clinical Infectious Diseases · doi:10.1086/313440 · Cited by 407
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Small, P. M., & Chambers, H. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1227 · Cited by 399
Moise-Broder, P. A., Sakoulas, G., Eliopoulos, G. M., Schentag, J. J., Forrest, A., & Moellering, R. C. (2004) · Clinical Infectious Diseases · doi:10.1086/421092 · Cited by 332
Performance standards for antimicrobial susceptibility testing : twelfth informational supplement
Ferraro, M. J. (2002) · Medical Entomology and Zoology · Cited by 316
Staphylococcus aureus bacteremia
Nolan, C. M., & Beaty, H. N. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90715-4 · Cited by 314
LaPlante, K. L., & Rybak, M. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4665-4672.2004 · Cited by 284
Fowler, V. G., Justice, A., Moore, C., Benjamin, D. K., Woods, C. W., Campbell, S., Reller, L. B., Corey, G. R., Day, N. P. J., & Peacock, S. J. (2005) · Clinical Infectious Diseases · doi:10.1086/427806 · Cited by 262
Self-citationSerum Vancomycin Concentrations: Reappraisal of Their Clinical Value
Cantu, T. G., Yamanaka-Yuen, N. A., & Lietman, P. S. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.4.533 · Cited by 230
Reed, S. D., Friedman, J. Y., Engemann, J. J., Griffiths, R. I., Anstrom, K. J., Kaye, K. S., Stryjewski, M. E., Szczech, L. A., Reller, L. B., Corey, G. R., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502523 · Cited by 200
Self-citationIncidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients
Marr, K. A., Kong, L., Fowler, V. G., Gopal, A., Sexton, D. J., Conlon, P. J., & Corey, G. R. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00134.x · Cited by 163
Self-citationComplications Associated With Staphylococcus aureus Bacteremia
Libman, H. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.144.3.541 · Cited by 159
Clinical Infectious Diseases: A Practical Approach
(1998) · doi:10.1093/oso/9780195081039.001.0001 · Cited by 156
Engemann, J. J., Friedman, J. Y., Reed, S. D., Griffiths, R. I., Szczech, L. A. M., Kaye, K. S., Stryjewski, M. E., Reller, L. B., Schulman, K. A., Corey, G. R., et al. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502580 · Cited by 151
Self-citationRecurrentStaphylococcus aureusBacteremia: Pulsed‐Field Gel Electrophoresis Findings in 29 Patients
Fowler, V. G., Kong, L., Corey, G. R., Gottlieb, G. S., McClelland, R. S., Sexton, D. J., Gesty‐Palmer, D., & Harrell, L. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314712 · Cited by 149
Self-citationFortún, J., Navas, E., Martínez‐Beltrán, J., Pérez‐Molina, J., Martín‐Dávila, P., Guerrero, A., & Moreno, S. (2001) · Clinical Infectious Diseases · doi:10.1086/320869 · Cited by 126
Editorial: Monitoring Serum Vancomycin Levels: Climbing the Mountain Because It Is There?
Moellering, R. C. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.4.544 · Cited by 123
Use of vancomycin in high-flux hemodialysis: Experience with 130 courses of therapy
Barth, R. H., & DeVincenzo, N. (1996) · Kidney International · doi:10.1038/ki.1996.393 · Cited by 106
Retrospective Evaluation of Therapies for Staphylococcus aureus Endocarditis
Gentry, C. A., Rodvold, K. A., Novák, R., Hershow, R. C., & Naderer, O. J. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03788.x · Cited by 72
Recurrent Staphylococcus aureus bacteremia
Hartstein, A. I., Mulligan, M. E., Morthland, V. H., & Kwok, R. Y. Y. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.670-674.1992 · Cited by 66
Infection with Antimicrobial‐resistant Microorganisms in Dialysis Patients
Berns, J. S. (2003) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2003.03009.x · Cited by 64
Cefazolin in chronic hemodialysis patients: A safe, effective alternative to vancomycin
Fogel, M., Nussbaum, P., Feintzeig, I., Wa, H., Gavin, J. P., & Kim, R. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9740155 · Cited by 57
Apellaniz, G., Valdés, M., Pérez, R., Martin, F., Soria, F., García, A. O., Gòmez, J., & Vicente, T. (1991) · Journal of Chemotherapy · doi:10.1080/1120009x.1991.11739072 · Cited by 19
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Self-citationLiu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 932
Epidemiology of Methicillin‐Resistant Staphylococcus aureus
Boucher, H. W., & Corey, G. R. (2008) · Clinical Infectious Diseases · doi:10.1086/533590 · Cited by 805
Self-citation
Metadata
- Authors
- Stryjewski, M. E., Szczech, L. A., Benjamin, D. K., Inrig, J. K., Kanafani, Z. A., Engemann, J. J., Chu, V. H., Joyce, M. J., Reller, L. B., Corey, G. R., & Fowler, V. G.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-15
- Volume
- 44
- Issue
- 2
- Pages
- 190-196
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2130566249
- Cited by
- 348
- References
- 29
- FWCI
- 12.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.